Analyzing a large cohort of breast cancer gene expression data, Liao et al. found that the distinct genomic profile of breast cancer at a young age (≤45 years) can only be observed in estrogen-receptor (ER)-positive cancer, whereas in ER-negative tumors, the unique biology vanishes [13]. This evidence concerns the gene ESR1 and breast carcinoma.